Ivabeat 5 Tablet contains Ivabradine 5mg, a selective sinus node inhibitor used primarily for the treatment of chronic stable angina pectoris and heart failure with reduced ejection fraction. Ivabradine acts by specifically inhibiting the If current in the sinoatrial node, resulting in heart rate reduction without affecting myocardial contractility or intracardiac conduction. This targeted mechanism helps to decrease myocardial oxygen demand, thereby alleviating angina symptoms and improving exercise tolerance. Ivabeat 5 is indicated for patients who are in sinus rhythm with a resting heart rate of 70 beats per minute or higher and who are either intolerant to beta-blockers or require additional heart rate control despite optimal beta-blocker therapy. The recommended dosage is one tablet twice daily, taken with meals to enhance absorption. Ivabradine is contraindicated in patients with acute decompensated heart failure, severe hepatic impairment, sick sinus syndrome, sinoatrial block, or third-degree atrioventricular block. Common adverse effects include bradycardia, hypertension, atrial fibrillation, and visual disturbances such as phosphenes. Ivabeat 5 should be used cautiously in patients with conduction abnormalities and monitored regularly for heart rate and rhythm. It is essential to adhere to prescribed dosing and consult a healthcare professional before initiating or discontinuing therapy.